Publications

2017

Gullett JC, Westblade LF, Green DA, Whittier S, Burd EM. Closing the Brief Case: Too Beta To Be a "B". J Clin Microbiol. 2017;55(6):1973-1974.
Totoraitis K, Magro CM, Friedman A. Serpiginous Purpuric Eruption of the Leg. J Drugs Dermatol. 2017;16(10):1036-1038.
Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, et al. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. Cell Rep. 2017;19(9):1858-1873.
Dinerman BF, Bernstein AN, Khani F, Hu JC. Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence. Urology. 2017;105:e1-e2.
Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, et al. Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients. Clin Lymphoma Myeloma Leuk. 2017;17(12):825-833.
Taatjes DJ, Bouffard N, von Turkovich M, Quinn AS, Wu X-, Vasovic LV, et al. Visualization of macro-immune complexes in the antiphospholipid syndrome by multi-modal microscopy imaging. Micron. 2017;100:23-29.
Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, et al. SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. Cancer Cell. 2017;31(3):436-451.
Katz JS, Frankel H, Ma T, Zagzag D, Liechty B, Ben Zeev B, et al. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation. Childs Nerv Syst. 2017;33(4):601-607.
Sun Q, Calderon B, Zhao Z. Discrepancies between two immunoassays for the determination of MPO and PR3 autoantibodies. Clin Chim Acta. 2017;470:93-96.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700